The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
0.235
-0.029 (-10.84%)
At close: Nov 14, 2024, 4:00 PM
0.260
+0.025 (10.54%)
After-hours: Nov 14, 2024, 7:58 PM EST

The Oncology Institute Stock Forecast

TOI's stock price has decreased by -90.78% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for TOI stock has a target of 2.50, which predicts an increase of 962.93% from the current stock price of 0.24.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $2.50 $2.50 $2.50 $2.50
Change +962.93% +962.93% +962.93% +962.93%
* Price targets were last updated on Feb 26, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for TOI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 222221
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222221

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jefferies
Jefferies
Strong Buy
Initiates
$2.5
Strong Buy Initiates $2.5 +962.93% Feb 26, 2024
Guggenheim
Guggenheim
Strong Buy
Maintains
$3$2
Strong Buy Maintains $3$2 +750.34% Jun 16, 2023
Guggenheim
Guggenheim
Hold
Maintains
$6$3
Hold Maintains $6$3 +1,175.51% Mar 20, 2023
Guggenheim
Guggenheim
Strong Buy
Maintains
$7$6
Strong Buy Maintains $7$6 +2,451.02% Nov 11, 2022
Jefferies
Jefferies
Strong Buy
Initiates
$10
Strong Buy Initiates $10 +4,151.70% Aug 15, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
418.81M
from 324.24M
Increased by 29.17%
Revenue Next Year
487.63M
from 418.81M
Increased by 16.43%
EPS This Year
-0.42
from -0.92
EPS Next Year
-0.16
from -0.42
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025
Revenue
155.41M187.52M203.00M252.48M324.24M418.81M487.63M
Revenue Growth
37.33%20.66%8.26%24.37%28.42%29.17%16.43%
EPS
--0.24-0.16-0.21-0.92-0.42-0.16
EPS Growth
-------
Forward PE
-------
No. Analysts -----22
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 435.4M 506.9M
Avg 418.8M 487.6M
Low 406.4M 473.1M

Revenue Growth

Revenue Growth 20242025
High
34.3%
21.0%
Avg
29.2%
16.4%
Low
25.3%
13.0%

EPS Forecast

EPS 20242025
High -0.44 -0.17
Avg -0.42 -0.16
Low -0.41 -0.16

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.